ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting – GlobeNewswire (press release)
|
ZIOPHARM Announces Presentation of Data from T–Cell Therapy Programs at ASH Annual Meeting
GlobeNewswire (press release) BOSTON, Dec. 10, 2017 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company developing new gene and cell-based immunotherapies for cancer, today announced data supporting its non-viral approach to rapid manufacture of … |
